Back

Quality of life (QoL) in patients with heart failure with preserved ejection fraction (HFpEF): a systematic review

28 August 2022 (10:15 - 10:55)
Organised by:
Congress Presentation Part of: Chronic heart failure - HFpEF - HFrEF - HFmREF Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jieling Chen

AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Determinants and prognostic impact of afterload mismatch after MitraClip implantation
Doctor F. Angelini (Turin, IT)
Abstract Slides
Presentation thumbnail
Heart failure with mildly reduced ejection fraction: not a mid-range prognosis
Doctor J. Borges-Rosa (Coimbra, PT)
Abstract Slides
Presentation thumbnail
The prognostic value of sleep disordered breathing and the hypoxemic burden in HFpEF patients
Miss S. Mourmans (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Systemic microvascular response to insulin is associated with risk of heart failure with preserved ejection fraction in women with type 2 diabetes
Doctor E. Dal Canto (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - HFpEF - HFrEF - HFmREF

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources